Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-4-methyl-5-oxo-5-propoxypentan-2-yl)amino)-4-oxobutanoic acid is an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan. The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure.